Prelude Capital Management’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-19,200
| Closed | -$77K | – | 1047 |
|
|
2025
Q1 | $77K | Sell |
19,200
-9,680
| -34% | -$38.8K | 0.01% | 974 |
|
|
2024
Q4 | $187K | Sell |
28,880
-7,004
| -20% | -$45.5K | 0.01% | 885 |
|
|
2024
Q3 | $199K | Buy |
35,884
+18,970
| +112% | +$105K | 0.01% | 971 |
|
|
2024
Q2 | $94.4K | Buy |
16,914
+1,114
| +7% | +$6.22K | 0.01% | 1010 |
|
|
2024
Q1 | $106K | Buy |
+15,800
| New | +$106K | 0.01% | 1082 |
|
|
2023
Q2 | – | Sell |
-18,172
| Closed | -$167K | – | 1054 |
|
|
2023
Q1 | $167K | Buy |
+18,172
| New | +$167K | 0.01% | 797 |
|